The DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index.
The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis
Abstract
The dissemination of Mycobacterium tuberculosis from the primary focus of infection is central to the pathogenesis of tuberculosis. Trafficking of bacteria to the regional lymph nodes is essential to the development of a protective T-cell mediated immune response, but bacteria trafficked within the bloodstream can lead to extra-pulmonary dissemination and some of the most devastating clinical consequences of tuberculosis. Yet how M. tuberculosis leaves the lungs is poorly understood. Here, we review the potential pathways and molecular mechanisms behind the dissemination of M. tuberculosis and consider the consequences to both host and bacteria. To disseminate M. tuberculosis must breach the alveolar epithelium and various bacterial factors have been implicated in this process. Heparin binding haemagglutinin adhesin (HBHA) enables M. tuberculosis to bind to sulphated glycoconjugates on epithelial cells; disruption of its synthesis severely impairs the ability of bacteria to disseminate from the lungs to the spleen. Two products of the M. tuberculosis RD1 gene locus, early secretory antigenic target 6 kDa (ESAT-6) and culture filtrate protein 10 kDa (CFP-10), have been linked to cell lysis and may enable bacteria to invade and spread within the alveolar epithelium. Recent studies in embryonic zebrafish indicate ESAT-6 may also stimulate the trafficking of infected macrophages within granulomas, thereby promoting the early dissemination of bacteria. These findings challenge conventional notions of the protective role of granulomas in mycobacterial infection and indicate M. tuberculosis has evolved specific mechanisms which utilise granulomas as foci of macrophage recruitment, infection, and subsequent bacterial dissemination. Further understanding of the pathways, mechanisms and consequences of M. tuberculosis dissemination could have a major impact in designing novel vaccines and therapeutic strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, MTB can multiply and spread to other organs of the body, resulting in extrapulmonary TB.195”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [195]
Citations
Cites
Immunobiology of Dendritic Cells
Banchereau, J., Brière, F., Caux, C., Davoust, J. M., Lebecque, S., Liu, Y., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,755
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S. K., Wise, R. P., Mirabile‐Levens, E., Kasznica, J. M., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,683
Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90001-2 · Cited by 1,678
Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., & Enk, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1213 · Cited by 1,538
A Mutation in the Interferon-γ –Receptor Gene and Susceptibility to Mycobacterial Infection
Newport, M. J., Huxley, C. M., Huston, S., Hawrylowicz, C. M., Oostra, B. A., Williamson, R., & Levin, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352602 · Cited by 1,198
Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function
Geijtenbeek, T. B. H., van Vliet, S. J., Koppel, E. A., Sánchez‐Hernández, M., Vandenbroucke‐Grauls, C. M. J. E., Appelmelk, B. J., & van Kooyk, Y. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021229 · Cited by 1,079
M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells
van der Wel, N., Hava, D., Houben, D., Fluitsma, D., van Zon, M., Pierson, J., Brenner, M., & Peters, P. J. (2007) · Cell · doi:10.1016/j.cell.2007.05.059 · Cited by 960
DC-SIGN: escape mechanism for pathogens
van Kooyk, Y., & Geijtenbeek, T. B. H. (2003) · Nature reviews. Immunology · doi:10.1038/nri1182 · Cited by 939
The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection
Davis, J. M., & Ramakrishnan, L. (2009) · Cell · doi:10.1016/j.cell.2008.11.014 · Cited by 907
Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency
Altare, F., Durandy, A., Lammas, D. A., Emile, J., Lamhamedi‐Cherradi, S., Deist, F. L., Drysdale, P., Jouanguy, E., Döffinger, R., Bernaudin, F., et al. (1998) · Science · doi:10.1126/science.280.5368.1432 · Cited by 843
Severe Mycobacterial and Salmonella Infections in Interleukin-12 Receptor-Deficient Patients
de Jong, R., Altare, F., Haagen, I.-A., Elferink, D. G., de Boer, T., Vriesman, P. J. C. V. B., Kabel, P. J., Draaisma, J. M. T., van Dissel, J. T., Kroon, F. P., et al. (1998) · Science · doi:10.1126/science.280.5368.1435 · Cited by 819
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
Reed, M. B., Domenech, P., Manca, C., Su, H., Barczak, A. K., Kreiswirth, B. N., Kaplan, G., & Barry, C. E. (2004) · Nature · doi:10.1038/nature02837 · Cited by 763
Hsu, T., Hingley-Wilson, S. M., Chen, B., Chen, M., Dai, A. Z., Morin, P. M., Marks, C. B., Padiyar, J., Goulding, C., Gingery, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1635213100 · Cited by 731
DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells
Tailleux, L., Schwartz, O., Herrmann, J., Pivert, E., Jackson, M., Amara, A., Legrès, L., Dreher, D., Nicod, L. P., Gluckman, J. C., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021468 · Cited by 653
Tubach, F., Salmon, D., Ravaud, P., Allanore, Y., Goupille, P., Bréban, M., Pallot‐Prades, B., Pouplin, S., Sacchi, A., Chichemanian, R.-M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24632 · Cited by 629
Wolf, A. J., Desvignes, L., Linas, B., Banaiee, N., Tamura, T., Takatsu, K., & Ernst, J. D. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071367 · Cited by 580
Wolf, A. J., Linas, B. S., Trevejo-Nuñez, G., Kincaid, E., Tamura, T., Takatsu, K., & Ernst, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2509 · Cited by 558
Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation
Boisson‐Dupuis, S., Dargemont, C., Fieschi, C., Thomassin, N., Rosenzweig, S. D., Harris, J., Holland, S. M., Schreiber, R. D., & Casanova, J. (2001) · Science · doi:10.1126/science.1061154 · Cited by 517
Caws, M., Thwaites, G. E., Dunstan, S. J., Hawn, T. R., Lan, N. T. N., Thương, N. T. T., Stepniewska, K., Huyen, M. N. T., Bang, N. D., Loc, T. H., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000034 · Cited by 500
Self-citationCaruso, A. M., Serbina, N. V., Klein, E. C., Triebold, K. J., Bloom, B. R., & Flynn, J. L. (1999) · PubMed · Cited by 489
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination
Pethe, K., Alonso, S., Biet, F., Delogu, G., Brennan, M. J., Locht, C., & Menozzi, F. D. (2001) · Nature · doi:10.1038/35084083 · Cited by 462
Activation of human dendritic cells following infection with Mycobacterium tuberculosis
Henderson, R. A., Watkins, S. C., & Flynn, J. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.2.635 · Cited by 432
Caruso, A. M., Serbina, N. V., Klein, E. C., Triebold, K. J., Bloom, B. R., & Flynn, J. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5407 · Cited by 418
Chackerian, A. A., Alt, J., Perera, T. V., Dascher, C. C., & Behar, S. M. (2002) · Infection and Immunity · doi:10.1128/iai.70.8.4501-4509.2002 · Cited by 407
Gao, L., Guo, S., McLaughlin, B., Morisaki, H., Engel, J. N., & Brown, E. J. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04261.x · Cited by 395
Identification of Risk Factors for Extrapulmonary Tuberculosis
Yang, Z., Kong, Y., Wilson, F. J., Foxman, B., Fowler, A. H., Marrs, C. F., Cave, M. D., & Bates, J. H. (2004) · Clinical Infectious Diseases · doi:10.1086/380644 · Cited by 385
Scanga, C. A., Mohan, V. P., Yu, K., Joseph, H. M., Tanaka, K. E., Chan, J., & Flynn, J. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.347 · Cited by 351
Bruns, H., Meinken, C., Schauenberg, P., Härter, G., Kern, P., Modlin, R. L., Antoni, C., & Stenger, S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38482 · Cited by 307
Smith, J., Manoranjan, J., Pan, M., Bohsali, A., Xu, J., Liu, J., McDonald, K. L., Szyk, A., LaRonde-LeBlanc, N. A., & Gao, L. (2008) · Infection and Immunity · doi:10.1128/iai.00614-08 · Cited by 300
How tumour necrosis factor blockers interfere with tuberculosis immunity
Harris, J., & Keane, J. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04146.x · Cited by 293
Preventing Tuberculosis with Bacillus Calmette-Guérin Vaccine: A Meta-Analysis of the Literature
Brewer, T. F. (2000) · Clinical Infectious Diseases · doi:10.1086/314072 · Cited by 283
Toll-like receptor pathways in the immune responses to mycobacteria
Quesniaux, V. F. J., Fremond, C., Jacobs, M., Parida, S. K., Nicolle, D. M., Yeremeev, V., Bihl, F., Erard, F., Botha, T., Drennan, M., et al. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.04.016 · Cited by 280
Quesniaux, V. F. J., Nicolle, D. M., Torres, D., Kremer, L., Guérardel, Y., Nigou, J., Puzo, G., Erard, F., & Ryffel, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4425 · Cited by 260
Cytokine/chemokine cascades in immunity to tuberculosis
Orme, I. M., & Cooper, A. M. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01438-8 · Cited by 247
Idiopathic Disseminated Bacillus Calmette-Guerin Infection: A French National Retrospective Study
Casanova, J., Blanche, S., Emile, J., Jouanguy, E., Lamhamedi‐Cherradi, S., Altare, F., Stephan, J., Bernaudin, F., Bordigoni, P., Turck, D., et al. (1996) · PEDIATRICS · doi:10.1542/peds.98.4.774 · Cited by 246
Lin, P. L., Myers, A. J., Smith, L. P., Bigbee, C., Bigbee, M., Fuhrman, C. R., Grieser, H. J., Chiosea, I., Voitenek, N. N., Capuano, S., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27271 · Cited by 245
von Garnier, C., Filgueira, L., Wikström, M. E., Smith, M. E., Thomas, J. A., Strickland, D. H., Holt, P. G., & Stumbles, P. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1609 · Cited by 243
Dichotomous Role of the Macrophage in Early Mycobacterium marinum Infection of the Zebrafish
Clay, H., Davis, J. M., Beery, D., Anna Huttenlocher, A., Lyons, S. E., & Ramakrishnan, L. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.06.004 · Cited by 243
Infection by Tubercular Mycobacteria Is Spread by Nonlytic Ejection from Their Amoeba Hosts
Hagedorn, M., Rohde, K. H., Russell, D. G., & Soldati, T. (2009) · Science · doi:10.1126/science.1169381 · Cited by 233
Reiley, W. W., Calayag, M. D., Wittmer, S. T., Huntington, J. L., Pearl, J. E., Fountain, J. J., Martino, C. A., Roberts, A. D., Cooper, A. M., Winslow, G. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801496105 · Cited by 223
The pathogenesis of tuberculous meningitis
R., A. (1934) · Tubercle · doi:10.1016/s0041-3879(34)80008-6 · Cited by 222
Levin, M., Newport, M. J., Kalabalikis, P., Klein, N. J., D'Souza, S., Brown, I. N., Lenicker, H. M., Agius, P. V., Davies, E. G., Thrasher, A. J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90059-4 · Cited by 218
Fate ofMycobacterium tuberculosiswithin Murine Dendritic Cells
Bodnar, K. A., Serbina, N. V., & Flynn, J. L. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.800-809.2001 · Cited by 215
The Trojan horse: survival tactics of pathogenic mycobacteria in macrophages
Nguyen, L., & Pieters, J. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.03.009 · Cited by 204
A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis
Thuong, N. T. T., Hawn, T. R., Thwaites, G. E., Tth., C., Lan, N., Ht, Q., Hieu, N. T., Aderem, A. A., Hien, T. T., Farrar, J., et al. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364405 · Cited by 194
Self-citationTuberculous meningitis and miliary tuberculosis: the Rich focus revisited
Donald, P. R., Schaaf, H. S., & SCHOEMAN, J. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.02.010 · Cited by 189
McDonough, K. A., & Kress, Y. (1995) · Infection and Immunity · doi:10.1128/iai.63.12.4802-4811.1995 · Cited by 185
Interaction of pathogenic mycobacteria with the host immune system
Houben, E. N. G., Nguyen, L., & Pieters, J. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.12.014 · Cited by 172
Bermudez, L. E., Sangari, F. J., Kolonoski, P., Petrofsky, M., & Goodman, J. R. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.140-146.2002 · Cited by 167
In a novel form of IFN-γ receptor 1 deficiency, cell surface receptors fail to bind IFN-γ
Jouanguy, E., Boisson‐Dupuis, S., Pallier, A., Döffinger, R., Fondanèche, M., Fieschi, C., Lamhamedi‐Cherradi, S., Altare, F., Emile, J., Lutz, P., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9166 · Cited by 157
Jain, S. K., Satyaseela, M. P., Lamichhane, G., Kim, K. S., & Bishai, W. R. (2006) · The Journal of Infectious Diseases · doi:10.1086/502631 · Cited by 148
Modeling the immune rheostat of macrophages in the lung in response to infection
Day, J., Friedman, A., & Schlesinger, L. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904846106 · Cited by 139
Sinsimer, D., Huet, G., Manca, C., Tsenova, L., Koo, M.-S., Kurepina, N. E., Kana, B. D., Mathema, B., Marras, S. A. E., Kreiswirth, B. N., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01663-07 · Cited by 139
Kong, Y., Cave, M. D., Zhang, L., Foxman, B., Marrs, C. F., Bates, J. H., & Yang, Z. H. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01459-06 · Cited by 130
Mycobacterium tuberculosis‐activated dendritic cells induce protective immunityin mice
Tascon, R. E., Soares, S. C., Ragno, S., Stavropoulos, E., Hirst, E. M. A., & Colston, M. J. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00963.x · Cited by 129
Potential role for ESAT6 in dissemination ofM. tuberculosisvia human lung epithelial cells
Kinhikar, A. G., Verma, I., Chandra, D., Singh, K. K., Weldingh, K. N., Andersen, P. L., Hsu, T., Jacobs, W. R., & Laal, S. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06959.x · Cited by 121
A role for dendritic cells in the dissemination of mycobacterial infection
Humphreys, I. R., Stewart, G. R., Turner, D. J., Patel, J., Karamanou, D. M., Snelgrove, R. J., & Young, D. B. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.12.023 · Cited by 118
Menozzi, F. D., Reddy, V. M., Cayet, D., Raze, D., Debrie, A., Dehouck, M., Cecchelli, R., & Locht, C. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.03.023 · Cited by 113
Dobos, K. M., Spotts, E. A., Quinn, F. D., & King, C. H. (2000) · Infection and Immunity · doi:10.1128/iai.68.11.6300-6310.2000 · Cited by 110
Newton, S. M., Smith, R. J., Wilkinson, K. A., Nicol, M. P., Garton, N. J., Staples, K. J., Stewart, G. R., Wain, J. R., Martineau, A. R., Fandrich, S. E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604283103 · Cited by 109
Marino, S., Myers, A. J., Flynn, J. L., & Kirschner, D. E. (2010) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2010.05.012 · Cited by 85
Locht, C., Hougardy, J., Rouanet, C., Place, S., & Mascart, F. (2006) · Tuberculosis · doi:10.1016/j.tube.2006.01.016 · Cited by 85
Caws, M., Thwaites, G. E., Stepniewska, K., Lan, N. T. N., Duyen, N. T., Phuong, N. T., Huyen, M. N. T., Phan, M., Loc, T. H., Chau, T. T. H., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01181-06 · Cited by 83
Self-citationMcMurray, D. N. (2003) · Tuberculosis · doi:10.1016/s1472-9792(02)00079-3 · Cited by 80
Jeon, B., Derrick, S. C., Lim, J., Kolibab, K., Dheenadhayalan, V., Yang, A. L., Kreiswirth, B. N., & Morris, S. L. (2008) · Infection and Immunity · doi:10.1128/iai.00019-08 · Cited by 77
Demonstration of spread by Mycobacterium tuberculosis bacilli in A549 epithelial cell monolayers
Castro‐Garza, J., King, C. H., Swords, W. E., & Quinn, F. D. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11258.x · Cited by 52
Mehta, P. K., Karls, R. K., WHITE, E. H., Ades, E. W., & Quinn, F. D. (2006) · Microbial Pathogenesis · doi:10.1016/j.micpath.2006.05.002 · Cited by 50
Ho, R. S., Fok, J. S., Harding, G. E., & Smith, D. W. (1978) · The Journal of Infectious Diseases · doi:10.1093/infdis/138.2.237 · Cited by 44
Fok, J. S., Ho, R. S., Arora, P., Harding, G. E., & Smith, D. W. (1976) · The Journal of Infectious Diseases · doi:10.1093/infdis/133.2.137 · Cited by 43
Disseminated tuberculosis complicating anti-TNF-α treatment
Dimakou, K., Papaioannides, D., Latsi, P. I., Katsimboula, S., Korantzopoulos, P. G., & Orphanidou, D. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2004.00061.x · Cited by 30
Byrd, T. F., Green, G. M., Fowlston, S. E., & Lyons, C. R. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5132-5139.1998 · Cited by 28
Fu, C.-L., Chuang, Y.-H., Huang, H.-Y., & Chiang, B. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03689.x · Cited by 13
The Cultivation of Tubercle Bacilli from the Circulating Blood in Miliary Tuberculosis1
Clough, M. C. (2019) · American Review of Tuberculosis · Cited by 12
Mycobacteraemia among HIV-1-infected patients in São Paulo, Brazil: 1995 to 1998
Hadad, D. J., Palaci, M., Pignatari, A. C. C., Lewi, D. S., Machado, M., Telles, M. A. S., Martins, M. C., Ueki, S. Y. M., Vasconcelos, G. M., & Palhares, M. C. A. (2004) · Epidemiology and Infection · doi:10.1017/s0950268803001535 · Cited by 11
Cited by
Sorted by citations
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Tuberculous meningitis: more questions, still too few answers
Thwaites, G. E., van Toorn, R., & Schoeman, J. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70168-6 · Cited by 482
Self-citationThe immunoregulatory landscape of human tuberculosis granulomas
McCaffrey, E., Donato, M., Keren, L., Chen, Z., Delmastro, A. C., Fitzpatrick, M. B., Gupta, S., Greenwald, N. F., Baranski, A., Graf, W., et al. (2022) · Nature Immunology · doi:10.1038/s41590-021-01121-x · Cited by 334
MAIT Cells in Health and Disease
Provine, N. M., & Klenerman, P. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-080719-015428 · Cited by 232
The pathogenesis of tuberculous meningitis
Davis, A., Rohlwink, U. K., Proust, A. M., Figaji, A. A., & Wilkinson, R. J. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0318-102r · Cited by 201
Metadata
- Authors
- Krishnan, N., Robertson, B. D., & Thwaites, G.
- Affiliations
- Imperial College London (GB)
- Corresponding author
- Krishnan, Nitya
- Venue
- Tuberculosis
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 90
- Issue
- 6
- Pages
- 361-366
- ISSN
- 1472-9792 (ISSN-L)
- OpenAlex
- W2059831659
- Cited by
- 178
- References
- 75
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 12 · 2023: 13 · 2022: 20 · 2021: 8 · 2020: 14 · 2019: 12 · 2018: 12 · 2017: 14 · 2016: 15 · 2015: 8 · 2014: 8 · 2013: 7 · 2012: 9
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Tuberculosis (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- Mycobacterium tuberculosis, alveolar epithelium, HBHA, ESAT-6, CFP-10, granuloma, macrophage trafficking, spleen, lymph node trafficking, T cell immunity, zebrafish model
- MeSH terms
- Antigens, Bacterial, Bacterial Proteins, Epithelial Cells, Humans, Lung, Membrane Proteins, Mycobacterium Infections, Mycobacterium tuberculosis, Phagocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review